Analysis Article • Jun 05
Have your own idea? Try our Stock Screener
Polish (WIG) Life Sciences Industry Analysis
UpdatedJun 20, 2026
DataAggregated Company Financials
Companies4
- 7D-3.0%
- 3M-21.6%
- 1Y-23.6%
- YTD-35.0%
Over the last 7 days, the Life Sciences industry has dropped 1.1%, driven by a pullback from Ryvu Therapeutics of 7.0%. The industry has fallen 24% in the last year. Earnings are forecast to grow by 34% annually.
Industry Valuation and Performance
Has the Polish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 20 Jun 2026 | zł1.0b | zł448.4m | -zł104,204,195.00 | n/a | -9.9x | 2.3x |
| Mon, 18 May 2026 | zł1.3b | zł459.0m | -zł112,091,596.00 | 724.7x | -11.2x | 2.7x |
| Wed, 15 Apr 2026 | zł1.2b | zł459.0m | -zł102,646,524.00 | 745.1x | -11.9x | 2.7x |
| Fri, 13 Mar 2026 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -10.9x | 2.9x |
| Sun, 08 Feb 2026 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -10.9x | 2.9x |
| Tue, 06 Jan 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -11.8x | 3.2x |
| Thu, 04 Dec 2025 | zł1.7b | zł465.3m | -zł131,570,820.00 | n/a | -12.7x | 3.6x |
| Sat, 01 Nov 2025 | zł1.3b | zł507.6m | -zł114,663,001.00 | 1456.6x | -11.4x | 2.6x |
| Mon, 29 Sep 2025 | zł1.4b | zł507.7m | -zł114,663,001.00 | 1492.1x | -12.3x | 2.8x |
| Wed, 27 Aug 2025 | zł1.5b | zł460.9m | -zł129,094,851.00 | 37.8x | -11.3x | 3.2x |
| Fri, 25 Jul 2025 | zł1.6b | zł461.1m | -zł128,888,382.00 | 35.9x | -12.1x | 3.4x |
| Sun, 22 Jun 2025 | zł1.3b | zł457.8m | -zł130,948,382.00 | n/a | -10x | 2.9x |
| Tue, 20 May 2025 | zł1.6b | zł448.2m | -zł125,701,382.00 | n/a | -12.5x | 3.5x |
| Thu, 17 Apr 2025 | zł1.4b | zł452.3m | -zł123,092,243.00 | 49.3x | -11.4x | 3.1x |
| Sat, 15 Mar 2025 | zł1.5b | zł440.9m | -zł62,900,243.00 | 32.4x | -24.1x | 3.4x |
| Mon, 10 Feb 2025 | zł1.7b | zł427.8m | -zł64,267,017.00 | 15.1x | -25.9x | 3.9x |
| Wed, 08 Jan 2025 | zł2.0b | zł427.0m | -zł65,964,174.00 | 16.9x | -30.9x | 4.8x |
| Fri, 06 Dec 2024 | zł2.3b | zł427.0m | -zł66,300,174.00 | 18.1x | -35.3x | 5.5x |
| Sun, 03 Nov 2024 | zł2.3b | zł413.2m | -zł64,500,689.00 | 20.8x | -35.2x | 5.5x |
| Tue, 01 Oct 2024 | zł2.3b | zł413.2m | -zł57,384,869.00 | 22.3x | -40.3x | 5.6x |
| Thu, 29 Aug 2024 | zł2.4b | zł413.4m | -zł37,576,869.00 | 18.3x | -65x | 5.9x |
| Sat, 27 Jul 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 18.4x | -77.1x | 6x |
| Mon, 24 Jun 2024 | zł2.4b | zł413.5m | -zł32,092,283.00 | 18.8x | -76x | 5.9x |
| Wed, 22 May 2024 | zł2.6b | zł428.1m | -zł27,509,283.00 | 18.2x | -93.9x | 6x |
| Fri, 19 Apr 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 18.2x | -97.4x | 6.1x |
| Sun, 17 Mar 2024 | zł2.6b | zł478.9m | -zł71,866,957.00 | 46.3x | -35.8x | 5.4x |
| Tue, 13 Feb 2024 | zł2.6b | zł494.7m | -zł51,178,957.00 | 45x | -50.1x | 5.2x |
| Thu, 11 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 46.8x | -49.6x | 5x |
| Sat, 09 Dec 2023 | zł2.5b | zł495.2m | -zł50,454,191.00 | 45.2x | -49.5x | 5x |
| Mon, 06 Nov 2023 | zł2.5b | zł512.0m | -zł37,354,934.00 | 31.1x | -66.6x | 4.9x |
| Wed, 04 Oct 2023 | zł2.8b | zł515.2m | -zł42,853,934.00 | 39.4x | -64.4x | 5.4x |
| Fri, 01 Sep 2023 | zł2.8b | zł507.8m | -zł51,598,105.00 | 43.1x | -53.7x | 5.5x |
| Sun, 30 Jul 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 45.9x | -46.1x | 5.5x |
| Tue, 27 Jun 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 43.6x | -45x | 5.4x |
Price to Earnings Ratio
-45x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.3x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 4.4% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -0.98% | |
| Healthcare | -1.20% | |
| Life Sciences | -2.98% | |
| Clinical Research and Equipment | -2.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NNG NanoGroup | zł2.30 | 0.4% +zł426.3k | -19.9% | PB3.2x |